Anic Equity¶
'#---------------------------------------------------------#'
Total return since start: 0.709 %¶
'#---------------------------------------------------------#'
Equity now: -----------------------------> 52200.79 Kr¶
Max Equity ever reached: ------------> 53120.35 Kr¶
Portfolio value: --------------------------> 45865.76 Kr¶
PnL: ---------------------------------------> -887.24 Kr¶
DD now: ---------------------------------> -1.731 %¶
Max portfolio DD since start: ----> -13.025 %¶
Updated:¶
'2023-06-13 11:50:06.277648'
Anic Portfolio Holdings¶
| volume | changePercent | value | profit | profitPercent | acquiredValue | |
|---|---|---|---|---|---|---|
| name | ||||||
| Nederman Holding | 11 | 3.400000 | 2343.000000 | 154.000000 | 7.040000 | 2189.000000 |
| BHG Group | 49 | -2.740000 | 677.670000 | 38.670000 | 6.050000 | 638.999984 |
| SynAct Pharma | 9 | -1.070000 | 666.900000 | 21.900000 | 3.400000 | 645.000003 |
| Embracer Group B | 26 | 1.430000 | 683.670000 | 21.670000 | 3.270000 | 661.999988 |
| Biotage | 4 | 0.390000 | 620.800000 | 17.800000 | 2.950000 | 603.000000 |
| Addtech B | 3 | 1.790000 | 715.800000 | 15.800000 | 2.260000 | 699.999999 |
| Vitrolife | 3 | 2.130000 | 690.000000 | 13.000000 | 1.920000 | 677.000001 |
| Eastnine | 6 | -2.960000 | 669.600000 | 12.600000 | 1.920000 | 657.000000 |
| Indutrade | 5 | 1.640000 | 1332.000000 | 12.000000 | 0.910000 | 1320.000000 |
| Xvivo Perfusion | 3 | -0.180000 | 855.000000 | 10.000000 | 1.180000 | 845.000001 |
| Sdiptech B | 3 | 0.140000 | 830.400000 | 8.400000 | 1.020000 | 822.000000 |
| Nolato B | 12 | -0.360000 | 655.800000 | 7.800000 | 1.200000 | 648.000000 |
| Addnode Group B | 6 | 1.360000 | 759.600000 | 7.600000 | 1.010000 | 751.999998 |
| BONESUPPORT HOLDING | 10 | -0.240000 | 1230.000000 | 6.000000 | 0.490000 | 1224.000000 |
| Latour B | 2 | 1.390000 | 452.200000 | 3.200000 | 0.710000 | 449.000000 |
| Fortnox | 10 | 3.550000 | 670.000000 | 2.000000 | 0.300000 | 668.000000 |
| NCC B | 7 | -0.530000 | 655.200000 | 1.200000 | 0.180000 | 653.999997 |
| NCC A | 6 | 1.840000 | 598.800000 | -0.200000 | -0.030000 | 598.999998 |
| Profoto Holding | 7 | -0.240000 | 579.600000 | -2.400000 | -0.410000 | 581.999999 |
| Lime Technologies | 2 | -1.010000 | 588.000000 | -5.000000 | -0.840000 | 593.000000 |
| Sampo Oyj SDB | 1 | -0.800000 | 498.000000 | -7.000000 | -1.390000 | 505.000000 |
| Volati | 5 | -4.550000 | 566.000000 | -8.000000 | -1.390000 | 574.000000 |
| Investor B | 3 | 0.370000 | 648.000000 | -10.000000 | -1.520000 | 657.999999 |
| Sedana Medical | 135 | -2.500000 | 4320.000000 | -11.000000 | -0.250000 | 4330.999935 |
| SCA A | 4 | -0.680000 | 586.400000 | -12.600000 | -2.100000 | 599.000000 |
| Humana | 40 | 1.240000 | 651.200000 | -22.800000 | -3.380000 | 674.000000 |
| Balco Group | 39 | -1.360000 | 1834.950000 | -40.050000 | -2.140000 | 1874.999997 |
| Lundin Gold | 7 | 1.380000 | 922.600000 | -51.400000 | -5.280000 | 973.999999 |
| Ambea | 68 | 1.050000 | 2484.720000 | -52.280000 | -2.060000 | 2537.000032 |
| Creades A | 7 | 1.420000 | 549.500000 | -61.500000 | -10.070000 | 610.999998 |
| Investor A | 16 | 0.230000 | 3464.000000 | -81.000000 | -2.280000 | 3545.000000 |
| New Wave B | 40 | -0.980000 | 3781.200000 | -134.800000 | -3.440000 | 3916.000000 |
| Gaming Innovation Group | 161 | -0.200000 | 4033.050000 | -154.950000 | -3.700000 | 4187.999942 |
| Wästbygg Gruppen B | 80 | -1.470000 | 2688.000000 | -183.000000 | -6.370000 | 2871.000000 |
| Bactiguard Holding B | 37 | -3.620000 | 2564.100000 | -402.900000 | -13.580000 | 2966.999993 |
| TOTAL | 45865.760000 | -887.240000 | -1.73109% | 46752.999863 |
Updated:¶
'2023-06-13 11:50:24.209316'
None
Last optimization/rebalancing:¶
'2023-05-05'
Next optimization/rebalancing:¶
'2023-06-15'
AVAN-Live vs backtest and OMXSE30 2023¶
Walk forward test results - depending on starting day¶
Equity is shown as log of returns. Returns range by a factor of 10. Best is about 10000%, 100 times money, and worst 1000%, 10 times money in 20 years. Maximal duration for drawdown periods vary between 280-750 days. Worst drawdown across the tests is about 40 %. ¶
